These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 31878999)

  • 41. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.
    Tang Y; Xiao G; Chen Y; Deng Y
    Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897
    [TBL] [Abstract][Full Text] [Related]  

  • 42. GRAIL inhibits the growth, migration and invasion of lung adenocarcinoma cells by modulating STAT3/C-MYC signaling pathways.
    Zhu Y; Feng YZWWJ
    J BUON; 2021; 26(2):353-358. PubMed ID: 34076979
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [USP33 suppresses lung adenocarcinoma lung cell invasion and metastasis by down-regulating SLIT2/ROBO1 signaling pathway].
    Wang Y; Zhang S; Mu S; Zhang B; Ma S
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Jul; 38(8):956-961. PubMed ID: 30187867
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Apigenin inhibits cell proliferation, migration, and invasion by targeting Akt in the A549 human lung cancer cell line.
    Zhou Z; Tang M; Liu Y; Zhang Z; Lu R; Lu J
    Anticancer Drugs; 2017 Apr; 28(4):446-456. PubMed ID: 28125432
    [TBL] [Abstract][Full Text] [Related]  

  • 45. FBXO17 promotes cell proliferation through activation of Akt in lung adenocarcinoma cells.
    Suber TL; Nikolli I; O'Brien ME; Londino J; Zhao J; Chen K; Mallampalli RK; Zhao Y
    Respir Res; 2018 Oct; 19(1):206. PubMed ID: 30359271
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumor-derived exosomal BCYRN1 activates WNT5A/VEGF-C/VEGFR3 feedforward loop to drive lymphatic metastasis of bladder cancer.
    Zheng H; Chen C; Luo Y; Yu M; He W; An M; Gao B; Kong Y; Ya Y; Lin Y; Li Y; Xie K; Huang J; Lin T
    Clin Transl Med; 2021 Jul; 11(7):e497. PubMed ID: 34323412
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Targeting the VEGF-C/VEGFR3 axis suppresses Slug-mediated cancer metastasis and stemness via inhibition of KRAS/YAP1 signaling.
    Yeh YW; Cheng CC; Yang ST; Tseng CF; Chang TY; Tsai SY; Fu E; Chiang CP; Liao LC; Tsai PW; Yu YL; Su JL
    Oncotarget; 2017 Jan; 8(3):5603-5618. PubMed ID: 27901498
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An AKT/PRMT5/SREBP1 axis in lung adenocarcinoma regulates de novo lipogenesis and tumor growth.
    Liu L; Yan H; Ruan M; Yang H; Wang L; Lei B; Sun X; Chang C; Huang G; Xie W
    Cancer Sci; 2021 Aug; 112(8):3083-3098. PubMed ID: 34033176
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long non-coding RNA SNHG15 indicates poor prognosis of non-small cell lung cancer and promotes cell proliferation and invasion.
    Dong YZ; Meng XM; Li GS
    Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2671-2679. PubMed ID: 29771418
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Small interference RNA targeting tissue factor inhibits human lung adenocarcinoma growth in vitro and in vivo.
    Xu C; Gui Q; Chen W; Wu L; Sun W; Zhang N; Xu Q; Wang J; Fu X
    J Exp Clin Cancer Res; 2011 May; 30(1):63. PubMed ID: 21619686
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High expression of keratin 6C is associated with poor prognosis and accelerates cancer proliferation and migration by modulating epithelial-mesenchymal transition in lung adenocarcinoma.
    Hu HB; Yang XP; Zhou PX; Yang XA; Yin B
    Genes Genomics; 2020 Feb; 42(2):179-188. PubMed ID: 31768767
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Poly (ADP-ribose) polymerase-1 Binding Protein Facilitates Lung Adenocarcinoma Cell Proliferation and Correlates with Poor Prognosis.
    Xu D; Tao Z; Tang X; He JK
    Ann Clin Lab Sci; 2019 Sep; 49(5):574-580. PubMed ID: 31611199
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of GLI1 correlates with expression of lymphangiogenesis proteins, vascular endothelial growth factor C and vascular endothelial growth factor receptor 3, in colorectal cancer.
    Hong KD; Lee Y; Kim BH; Lee SI; Moon HY
    Am Surg; 2013 Feb; 79(2):198-204. PubMed ID: 23336661
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IGF2BP3 aggravates lung adenocarcinoma progression by modulation of PI3K/AKT signaling pathway.
    Chen X; Zhu X; Shen X; Liu Y; Fu W; Wang B
    Immunopharmacol Immunotoxicol; 2023 Jun; 45(3):370-377. PubMed ID: 36972188
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Elevation of CD109 promotes metastasis and drug resistance in lung cancer via activation of EGFR-AKT-mTOR signaling.
    Lee KY; Shueng PW; Chou CM; Lin BX; Lin MH; Kuo DY; Tsai IL; Wu SM; Lin CW
    Cancer Sci; 2020 May; 111(5):1652-1662. PubMed ID: 32133706
    [TBL] [Abstract][Full Text] [Related]  

  • 56. EZH2 promotes tumor progression via regulating VEGF-A/AKT signaling in non-small cell lung cancer.
    Geng J; Li X; Zhou Z; Wu CL; Dai M; Bai X
    Cancer Lett; 2015 Apr; 359(2):275-87. PubMed ID: 25633838
    [TBL] [Abstract][Full Text] [Related]  

  • 57. microRNA-935 is reduced in non-small cell lung cancer tissue, is linked to poor outcome, and acts on signal transduction mediator E2F7 and the AKT pathway.
    Wang C; Li S; Xu J; Niu W; Li S
    Br J Biomed Sci; 2019 Jan; 76(1):17-23. PubMed ID: 30203720
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CALU promotes lung adenocarcinoma progression by enhancing cell proliferation, migration and invasion.
    Li Y; Sun S; Zhang H; Jing Y; Ji X; Wan Q; Liu Y
    Respir Res; 2024 Jul; 25(1):267. PubMed ID: 38970088
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression and Comparison of Cbl-b in Lung Squamous Cell Carcinoma and Adenocarcinoma.
    Li P; Liu H; Zhang Z; Lv X; Wang H; Ma J; Ma Z; Qu X; Teng YE
    Med Sci Monit; 2018 Jan; 24():623-635. PubMed ID: 29384143
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anlotinib suppresses lymphangiogenesis and lymphatic metastasis in lung adenocarcinoma through a process potentially involving VEGFR-3 signaling.
    Qin T; Liu Z; Wang J; Xia J; Liu S; Jia Y; Liu H; Li K
    Cancer Biol Med; 2020 Aug; 17(3):753-767. PubMed ID: 32944404
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.